LUKAS BIOMEDICAL INC.
Area: Cell Therapy and Regenerative Medicine
Booth No: N/A
Website: https://lukas-bio.com.tw/
Exhibitor Profile
Lukas’ primary memory T cell technology is developed in collaboration with the National Cancer Center of Japan. The technology has been validated through 2 Phase III clinical trials in Japan and Korea and has been certified by Korea FDA. Post-marketing Phase IV clinical trial data is therefore available validating the efficacy of our technology and more than 10,000 people have received such Memory T cell treatment in Japan and Korea and Taiwan.
Brands
Lukas Biomedical Inc.
Video
Exhibit Products
Exhibitors you may be interested in
Highest Rated